CN107164309A - The 3D models and its construction method of a kind of utilization serum-containing medium external structure - Google Patents
The 3D models and its construction method of a kind of utilization serum-containing medium external structure Download PDFInfo
- Publication number
- CN107164309A CN107164309A CN201710460520.4A CN201710460520A CN107164309A CN 107164309 A CN107164309 A CN 107164309A CN 201710460520 A CN201710460520 A CN 201710460520A CN 107164309 A CN107164309 A CN 107164309A
- Authority
- CN
- China
- Prior art keywords
- cell
- concentration
- models
- culture
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0632—Cells of the oral mucosa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides, bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/905—Hyaluronic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The present invention discloses a kind of 3D models and its construction method built in vitro using system containing serum free culture system, is related to organizational engineering technical field of biological materials, and because the seed cell selection of the 3D models is various, external structure repeatability is good, and industrialization can be achieved and prepares；Meanwhile, using system containing serum free culture system, there is provided the addition that the factor while nutrition, is reduced needed for cell.The model is application cell biology and engineering principles, the primary corneal epithelial cell separated using tissue, or limbal stem cell, or immortalize corneal epithelial cell, or primary Buccal mucosa cell, or mucous membrane of mouth squamous cancer cell strain TR146, after amplification in vitro, using gas-liquid face subsection filter method under serum-containing medium, and liquid, make its cladding, form external 3D models.
Description
Technical field
The invention belongs to organizational engineering technical field of biological materials, and in particular to one kind is existed using system containing serum free culture system
The 3D models and its construction method of external structure.
Background technology
3D models are application cell biology and engineering principles in the present invention, by a small amount of seed cell after amplification in vitro
Built-up, its structure is highly similar with Corneal epithelial structure, structure from bottom to top be followed successively by basalis, spinous layer,
Stratum granulosum, spinous layer, equal anoderm with complete epithelial structure, and express the related keratin of cornea.The 3D of the external structure
Model is mainly used as Eye irritation vitro detection, and micromolecular compound, activated protein, medicine equipment, chemicals, cosmetics etc. are produced
The security of product is evaluated.
Chemicals are directly contacted or exposed to eye, can releasing stimulus and local toxicity.Therefore, ocular excitant
Risk assessment is in demand one in hazard assessment and risk averse program.To the eye of new compound in conventional method
The assessment of potential risk is stimulated to depend on external lagophthalmos experiment, this method takes time and effort and cost is higher.Therefore,
Finding quick, economic method for screening compound turns into an active demand in the field, and excites substantial amounts of on ocular
The development of the related work of the foundation of the external alternative of excitant risk assessment, such as ox horn film opacity and permeability
Detection, Chick chorioallantoic membrane assay etc., above-mentioned technology can realize external eye irritation evaluation by a certain degree of combination, but
The replacement of external lagophthalmos stimulation test can not all be fully achieved.In recent years, with the development of vitro in organ's culture technique, based on body
The 3D restructuring corneal epithelium models that outer cell culture is built, distinctive trend is shown in Eye irritation risk assessment field.In vitro
The 3D corneal epithelium models of structure, similar to the three-dimensional structure of human cornea epithelium, it not only more can really reflect people
Response of the body to chemicals, accurately provides the irritating prediction of chemicals, for screening compound species also have it is broader
Application category, except the formulation development of different efficacies purpose, also includes the hazard assessment of the specific composition of cosmetics.At present, use
The eye irritation detection that external structure 3D restructuring cornea models are carried out is by international endorsement, and OECD guides 492 are provided within 2015
Using a kind of alternative of the model.
At present, mainly there are three kinds of commercialized vitro recombination corneal epithelium models, first item EpiOcular in the world
(MatTek, MA, USA), HCE (Skin Ethic, France) and CORNEA-MODEL（Labcyte, Japen）.Its
In, MatTek EpiOcularTMUsing the epidermal keratinocytes in people source as seed cell, in vitro culture formation is similar to angle
The model of film epithelial structure, although the model plays important role in eye irritation animal substitutes evaluation method, but non-
Keratocyte system can not be fully equivalent to people's cornea.Labcyte CORNEA-MODEL is thin using normal people's corneal epithelium
Born of the same parents system is built, in vitro culture formation corneal epithelium structure；Corneal epithelial cell is in vitro study cell differentiation, signal biography
Lead, the mode facility of Cell Homeostasis signal path, may also be used for building corneal epithelial tissue's model of external three-dimensional, still,
The limited availability of cornea tissue can be used, the of short duration life cycle of keratocyte itself and quickly differentiation in addition so that cornea
Epithelial cell in vitro culture difficulty is big, and takes very much.Many trials increase the work in corneal epithelial cell in vitro culture cycle
There are development, such as virus transfection, the transfection of Telomerase retroviral gene etc., Skin Ethic HCE models are using immortalization
Characteristic Analysis of Corneal Epithelial Cell Line is cultivated as seed cell, is formed in corneal epithelial tissue's analog of cell rich zone, its structure
It is very similar with cornea mucous membrane.
The application of Chinese patent 201410062366 discloses a kind of simple limbal stem cell separation and in vitro culture reagent
Box and method, limbal stem cell separation and in vitro culture are carried out using this method, and simple to operate, stem cell yield is high, gained
Primary stem cell injuries are few, and competence for added value is strong, and in vitro culture success rate is high, favorable reproducibility.
The application of Chinese patent 03150375.6 discloses a kind of tissue engineering autologous cornea epithelium and preparation method thereof, the party
After method will be expanded and broken up in vitro from the corneal epithelial stem cells and corneal epithelial cell of autologous patient, fiber is inoculated into
Cultivated on protein biology support, tissue engineering autologous cornea epithelium is built in vitro.
Chinese patent 200410019341.X applications disclose a kind of cornea edge stem cell tissue engineering composite body and its system
Preparation Method, this method, as carrier, using 3T3 fibroblasts as trophoderm, is built in vitro using the amnion for removing epithelium
Tissue engineering comea complex.
Chinese patent 200410019342.4 is applied disclosing the human limbal stem cell that a kind of human fibroblasts are nourished
Tissue engineering product and preparation method, this method, as carrier, taste are used as using human fibroblasts using the amnion for removing epithelium
Layer is supported, tissue engineering comea complex is built in vitro.
The application of Chinese patent 201019018004.1 discloses a kind of preparation method of tissue engineering comea, and this method is used
Epidermal stem cells and multipotency stroma stem cell are seed cell, and de- cell natural cornea matrix is planted in after amplification in vitro culture
Two sides, then through it is external evoked culture form tissue engineering comea.
The cell derived of corneal epithelium model includes embryonic stem cell, mescenchymal stem cell, skin progenitor cell and oral cavity
Mucosal epithelial cells etc., it there has been as the zoopery and clinical practice of seed cell and reports and achieve breakthrough to enter
Exhibition, especially for the research of Buccal mucosa cell, has become focus at present.At present in clinical treatment, mouth is used
Chamber mucosal epithelial cells build biological diaphragm transplantation treatment eye surface diseases, and this method turns into common method in clinical treatment.From
The epithelial cell of mucous membrane of mouth separation is in relatively low differential period compared with epidermal keratinocytes, due to its cell cycle week
Phase relative brevity, Time in Vitro can also shorten, and the Extending culture time can also maintain non-angling state；Secondly, living group is taken
The scar remained after knitting is not obvious, turns into oral cavity and obtains a living tissue ideal place.Shigeru and Nakamura etc. refers to
Go out, Oral mucosa keratinocyte tissue is made up of 5 ~ 6 confluent monolayer cells, with basalis, spinous layer, stratum granulosum, anoderm, and there is bridge
The tight connecting devices such as grain, hemidesmosome, the institutional framework is similar to cornea tissue structure；And study discovery Oral mucosa keratinocyte
Cell expression non-keratinocyte layer differential protein CK4, CK13, and cornea differential protein CK3.Yasutaka etc. is studied and also indicated that, oral cavity
Mucosal epithelial cells expression cornea differential protein CK3, non-keratinocyte layer differential protein CK4, CK13, and cuticula differential protein CK1,
CK10 is without expression, and its expression is identical with the expression of keratin in cornea.
Successful application of the Buccal mucosa cell on clinical treatment, illustrates that Buccal mucosa cell can be as angle
Film epithelial cell ideal substitute is used for ocular surface reconstruction, shows that Buccal mucosa cell has and substitutes keratocyte structure in vitro
The potential of model.
The application of Chinese patent 200610128698.0 discloses a kind of preparation method of epithelium of autologous cornea, and this method is used
The oral cavity mucous membrane tissue cell of original cuiture autologous patient 3 ~ 15 days, passage amplification cultivation is carried out to gained cell 7 ~ 30 days, then
Progress culture structure on fibrin biological support is inoculated into, corneal epithelium is finally prepared into, applied to clinical treatment.But at present
The cornea model built using Oral Mucosal Cells, it builds, and the time is long, and a collection of model of external structure need to be up to one month,
The long structure time can increase during uncontrollable factor, influence model stability；Trophoderm is needed, is that epithelial layer is carried
For nutrition；It is applied to clinical treatment more.
At present, external structure tissue engineering comea is applied to clinical treatment mostly, and restricts tissue engineering comea transplanting
Bottleneck is carrier construction, therefore the research of tissue engineering comea is concentrated mainly on carrier construction, and its constructive system is also more fitted
Carrier is closed, and needs trophoderm to provide nutrition for epithelial layer mostly.In addition, the cornea model built at present using keratocyte,
Its structure time is long, and a collection of model of external structure need to be during one month, long structure time can increase not
Controllable factor, influences the stability of model.
The content of the invention
The embodiments of the invention provide a kind of 3D models built in vitro using system containing serum free culture system and its structure side
Method, because the seed cell selection of the 3D models is various, external structure repeatability is good, and industrialization can be achieved and prepares；Meanwhile, use
There is provided the addition that the factor while nutrition, is reduced needed for cell for system containing serum free culture system；And cultivating system is built to be more suitable for
The Proliferation, Differentiation of epithelial cell, makes cell also can cladding well differentiated without matrix and support, it is ensured that the normal cladding of model
Change, so as to form the attachment structure similar with human cornea epithelial height, and normal expression corneal epithelium GAP-associated protein GAP.
Present invention is as follows：
A kind of 3D models, the model is the 3D models and its construction method of a kind of utilization serum-containing medium external structure, is
Application cell biology and engineering principles, the primary corneal epithelial cell separated using tissue, or limbal stem cell, or forever
Biochemical corneal epithelial cell, or primary Buccal mucosa cell, or mucous membrane of mouth squamous cancer cell strain TR146, through external expansion
After increasing, using under serum-containing medium, and liquid-gas-liquid face subsection filter method, make its cladding, form external 3D models.
Further, the primary corneal epithelial cell that cell used separates for use tissue, or limbal stem cell, or
Immortalize one in corneal epithelial cell, or primary Buccal mucosa cell, or mucous membrane of mouth squamous cancer cell strain TR146
Kind.
Further, the culture medium used contains 5% ~ 20% hyclone FBS.
A kind of vitro construction method of utilization serum-containing medium external structure 3D models, including following methods step：
Step 1: the preparation of cell
Primary corneal epithelial cell, or limbal stem cell are taken, or immortalizes corneal epithelial cell, or primary Oral mucosa keratinocyte
Cell, or mucous membrane of mouth squamous cancer cell strain TR146, after recovery amplification, using P4 ~ P20 for cell, list is made with pancreatin digestion
Cell suspension, adjusts cell density 5.0 × 104Individual/mL~5.0 × 106Individual/mL, is inoculated in blake bottle, plus containing 5% ~ 20% tire
The nutrient solution I of cow's serum is cultivated, and gently rocks blake bottle, makes after cell is uniformly dispersed, to be placed in 37 DEG C, 5%CO2Under the conditions of cultivate；
The nutrient solution I, is DMEM, its contained glucose content be 1.0~4.5g/L, glutamine content be 0.2g/L~
20.0g/L。
Step 2: inoculated and cultured under the liquid of 3D models
Take the logarithm growth period cell, single cell suspension is made with nutrient solution II, adjustment cell density is 5.0 × 104Individual/mL~
5.0×106Individual/mL, with the volume of 200 μ L/ rooms, is inoculated in small interior, cell is placed in model culture dish, and per ware, addition is suitable
Nutrient solution II is measured, makes small indoor and outdoor liquid level consistent, immersion culture is carried out；It is placed in 37 DEG C, 5%CO2Under the conditions of cultivate 0.5
~2 hours, after be transferred under liquid cultivate, incubation time be 1~3 day, liquid is changed daily；
The nutrient solution II, is with DMEM：F12 contents are 3:1~1:Culture medium based on 3 culture medium, adds hyclone
Concentration is 5%~20%, and vitamin A acid concentration is 4~10 μ g/mL, and hEGF's concentration is 0.1~10.0 ng/mL, pancreas islet
Plain concentration is 5.0~50.0 ng/mL, and hydrocortisone concentration is 0.1~5.0 μ g/mL, and adenine concentration is 5.0~50.0
μ g/mL, triiodothyronine concentration is 0.1~10.0 μ g/mL, and hyaluronic acid concentration is 0.01%~0.1%, flavones concentration
For 5.0~50.0 μ g/mL, glutamine concentration is 0.2g/L~20.0g/L, and cholera toxin concentration is 1.0~100.0 μ g/
L, amphomoronal concentration is 1.0~10.0 mg/L, and penicillin concn is 10.0~100.0 IU/mL, and streptomysin concentration is
10.0~100.0 μ g/mL；
The nutrient solution II used in above-mentioned steps, on the basis of basic culture solution, with the addition of and contain in hyclone, hyclone
There are various plasma proteins, polypeptide, fat, carbohydrate, growth factor, hormone, inorganic matter etc., using the teaching of the invention it is possible to provide artificial synthesized training
Biotic factor lacking in nutrient solution and physical factor, form the cell growth place similar to internal microenvironment, give birth to cell
Long or suppression reaches physiological equilibrium.Also, there is scholar's research to find that the cell of free serum culture seems only in matrix or support
Well cladding mucous membrane piece could be differentiated to form on material, and add the culture medium of serum, cell can also be answered without matrix and support
Layer well differentiated.But the composition of some in serum also can produce certain inhibitory action, therefore, nutrient solution to the differentiation of epithelial cell
The various factors are with the addition of in II, propagation and the differentiation of cell is adjusted.Wherein vitamin A acid can promote epithelial hyperplasia, differentiation,
The metabolism such as cutin dissolving.Hydrocortisone may have rush cell attachment and proliferation function concurrently, can induce when cell density is high
Cell breaks up.The straight chain polymer that hyaluronic acid is glucuronic acid and-N second phthaleins Glucosamine is dissacharide units composition is more
Sugar, the regulation of solution osmotic pressure can be carried out containing substantial amounts of carboxyl and hydroxyl with water formation hydrogen bond with reference to substantial amounts of water；And
And there are a variety of protective effects to cell, there is interception to the diffusion with macromolecular, also have to cell behavior certain
Influence；Hyaluronic acid can also suppress the formation and release of free radical., can be with peroxidating certainly containing abundant aldehydes matter in flavones
Closed by base junction, block the progress of peroxidating chain reaction, improve the oxidation resistance of cell；Flavones can also pass through reduction
The expression of Caspase-3 albumen suppresses the generation of Apoptosis.For single culture medium used in tradition culture（For example it is single
Pure use DMEM culture mediums）It is merely able to provide amino acid, vitamin, inorganic salts, organic compound, the defect of trace element, this
The addition of a little factors, on the one hand ensure that the nutritional need of cell, promotes the growth of cell；Another aspect oozing from culture medium
The activity of cell is ensure that in terms of saturating pressure and oxidation resistance.
Step 3: the gas-liquid face Proliferation, Differentiation culture of 3D models
Above-mentioned small indoor nutrient solution is discarded, the nutrient solution changed in model culture dish is nutrient solution III, makes liquid level and cell
Inner cell upper surface is located at same horizontal line, carries out gas-liquid face culture, and incubation time is 1~7 day, liquid is changed daily, culture terminates,
The external structure of model terminates；
The nutrient solution III, is that in nutrient solution II, increase hydrocortisone concentration is 5.0~10.0 μ g/mL, hyaluronic acid
Concentration is 0.1%~1%, and flavones concentration is 50.0~150.0 μ g/mL, and adds Vitamin E levels for 20.0~80.0 μ g/
mL。
The method that gas-liquid face subsection filter is used in above-mentioned steps, makes its cladding, forms external model.Train in the gas-liquid face
The nutrient solution III that the foster stage uses, the difference with nutrient solution II is, adds hydrocortisone, hyalomitome in nutrient solution II
Acid, the concentration of flavones, and with the addition of vitamin E.Vitamin E is one of topmost antioxidant, protects cells from freedom
The murder by poisoning of base, suppresses Apoptosis；And cell can be reduced need oxygen amount, maintain cytoactive；And participate in the synthesis of cell DNA.
The appropriate increase of hydrocortisone concentration, can play the effect of Cell differentiation inducing activity in the case of cell density is increased,
It ensure that the complete cladding of model.On the one hand hyaluronic acid suppresses the formation and release of free radical, on the one hand maintains cell normal
Osmotic pressure needed for metabolism, so as to ensure that the propagation of cell, differentiation.The increase of flavones concentration, further suppresses cell fast
Apoptosis in fast-growing growth process.Above-mentioned condition collective effect, it is ensured that the propagation of the quick health of cell, differentiation, is ultimately formed multiple
Stratification corneal epithelium structure, and the construction method simplified, shorten the structure time.
Further, the model construction time is 3 ~ 10 days, short the time required to building.
Further, constructive system can provide nutrition and microenvironment needed for epithelial cell proliferation differentiation, it is not necessary to nourish
Layer.
Further, model structure is similar to Corneal epithelial structure, is multiple layered structure, anoderm.
Further, the expression of model cornea specific proteins is similar to Corneal epithelium, expresses cornea specific protein
White CK3.
Further, using ET50 methods（0.3% Triton X-100 make the time in model needed for half cell death）
Its barrier function is detected, after culture terminates under liquid, its ET50 is 5 ~ 15min.
Further, detect its barrier function using ET50 methods, gas-liquid face culture terminate after, its ET50 be 30 ~
70min。
Further, the model is applied to the production such as micromolecular compound, activated protein, medicine equipment, chemicals, cosmetics
The eye irritation vitro detection of product.
The beneficial effects of the invention are as follows：
The 3D models that the method provided using the present invention is built, with advantages below：One, seed cell selects various, external structure
Build repeatability good, industrialization can be achieved and prepares；2nd, using system containing serum free culture system, there is provided while nutrition, reduced needed for cell
The addition of the factor；Three, on the one hand the addition of hyaluronic acid suppresses the formation and release of free radical, on the one hand can carry out solution
The regulation of osmotic pressure, maintains the osmotic pressure needed for cell eubolism, so as to ensure that the propagation of cell, differentiation；4th, flavones
Addition, reduces the expression of Caspase-3 albumen, so as to inhibit the generation of Apoptosis；5th, under liquid and the gas-liquid face stage not
Same hydrocortisone concentration, it is ensured that the demand of cell different times, is conducive to the formation of cladding corneal epithelium structure；
6th, the simplification of gas-liquid face cultivation stage, while the differentiation of cell fast breeding is ensured, shortens structure time, reduction production
Cost；Seven, the structure cultivating system is more suitable for the Proliferation, Differentiation of epithelial cell, makes cell also can cladding point without matrix and support
Change good, it is ensured that the normal cladding of model, so that the attachment structure similar with human cornea epithelial height is formd, and just
Often express corneal epithelium GAP-associated protein GAP, the influence of this self structure and extracellular microenvironment can further lift scheme screen
Hinder function, the external 3D models finally built have highly similar structure and function to people corneal epithelial tissue；Eight, use structure
The 3D models pair built《Global chemicals homogeneous classification and labeling system》Middle part chemicals is detected, is as a result shown, is used
3D models prepared by the method that the present invention is provided can accurately judge whether the chemicals has eye irritation, its result and lagophthalmos
The result of determination of experiment is consistent, and therefore, 3D models are capable of the reflection testing result of objective reality, can be good at substituting animal mould
Type, the core tool as testing in vitro, applied to micromolecular compound, activated protein, medicine equipment, chemicals, cosmetics
Deng the eye irritation vitro detection of product.
Brief description of the drawings
Fig. 1 is Histological section's HE stained photographs of the 3D models using serum-containing medium external structure；
Fig. 2 is the keratin CK3 immunohistochemical staining photos of the 3D models using serum-containing medium external structure；
Fig. 3 is to terminate rear tissue activity and 0.3% using culture under the liquid of the 3D models of serum-containing medium external structure
The curve map of Triton X-100 action times, can calculate ET50 values；
Fig. 4 is to terminate rear tissue activity and 0.3% using the gas-liquid face culture of the 3D models of serum-containing medium external structure
The curve map of Triton X-100 action times, can calculate ET50 values；
Fig. 5 is to carry out compound eye irritation testing result figure using the 3D models of serum-containing medium external structure.
Embodiment
Below by specific implementation example, the invention will be further described, is not intended as limitations on claims.
Embodiment 1：
The present embodiment highlights the vitro construction method step of the 3D models using primary corneal epithelial cell external structure：
Step 1: the preparation of cell
Primary corneal epithelial cell is taken, after recovery amplification, using P7 for cell, single cell suspension is made with pancreatin digestion, adjusted
Cell density 5.0 × 104Individual/mL, is inoculated in blake bottle, plus the nutrient solution I of 10% hyclone is cultivated, and gently rocks culture
Bottle, makes after cell is uniformly dispersed, to be placed in 37 DEG C, 5%CO2Under the conditions of cultivate；
The nutrient solution I, is DMEM, and its contained glucose content is 1.0g/L, and glutamine content is 0.2g/L.
Step 2: inoculated and cultured under the liquid of 3D models
Take the logarithm growth period cell, single cell suspension is made with nutrient solution II, adjustment cell density is 5.0 × 104Individual/mL, with
The volume of 200 μ L/ rooms, is inoculated in small interior, cell is placed in model culture dish, and appropriate nutrient solution II is added per ware, is made small
Indoor and outdoor liquid level is consistent, carries out immersion culture；It is placed in 37 DEG C, 5%CO2Under the conditions of cultivate 0.5 hour, after be transferred under liquid
Culture, incubation time is 3 days, and liquid is changed daily；
The nutrient solution II, is with DMEM：F12 contents are 3:Culture medium based on 1 culture medium, adding hyclone concentration is
20%, vitamin A acid concentration is 8 μ g/mL, and hEGF's concentration is 0.8ng/mL, and insulin concentration is 20.0 ng/mL, hydrogen
It is 0.5 μ g/mL to change cortisone concentration, and adenine concentration is 25.0 μ g/mL, and triiodothyronine concentration is 0.1 μ g/mL, thoroughly
Bright matter acid concentration is 0.1%, and flavones concentration is 10.0 μ g/mL, and glutamine concentration is 0.2g/L, and cholera toxin concentration is 1.0
μ g/L, amphomoronal concentration is 1.0 mg/L, and penicillin concn is 100.0 IU/mL, and streptomysin concentration is 100.0 μ g/
mL；
Step 3: the gas-liquid face Proliferation, Differentiation culture of 3D models
Above-mentioned small indoor nutrient solution is discarded, the nutrient solution changed in model culture dish is nutrient solution III, makes liquid level and cell
Inner cell upper surface is located at same horizontal line, carries out gas-liquid face culture, and incubation time is 7 days, liquid is changed daily, culture terminates, 3D
The external structure of model terminates；
The nutrient solution III, is that in nutrient solution II, increase hydrocortisone concentration is 10.0 μ g/mL, and hyaluronic acid concentration is
1%, flavones concentration is 100.0 μ g/mL, and adds Vitamin E levels for 50.0 μ g/mL.
Histological section's HE coloration results using the 3D models of primary corneal epithelial cell external structure are shown in Fig. 1, explanation
Utilize the 3D model cladding structural integrities of primary corneal epithelial cell external structure.
Embodiment 2：
The present embodiment highlights the vitro construction method step using the 3D models for immortalizing corneal epithelial cell external structure：
Step 1: the preparation of cell
Immortalization corneal epithelial cell is taken, after recovery amplification, using P20 for cell, single cell suspension is made with pancreatin digestion, adjusted
Whole cell density 5.0 × 105Individual/mL, is inoculated in blake bottle, plus the nutrient solution I of 10% hyclone is cultivated, and gently rocks training
Bottle is supported, makes after cell is uniformly dispersed, to be placed in 37 DEG C, 5%CO2Under the conditions of cultivate；
The nutrient solution I, is DMEM, and its contained glucose content is 4.5g/L, and glutamine content is 0.2g/L.
Step 2: inoculated and cultured under the liquid of 3D models
Take the logarithm growth period cell, single cell suspension is made with nutrient solution II, adjustment cell density is 5.0 × 105Individual/mL, with
The volume of 200 μ L/ rooms, is inoculated in small interior, cell is placed in model culture dish, and appropriate nutrient solution II is added per ware, is made small
Indoor and outdoor liquid level is consistent, carries out immersion culture；It is placed in 37 DEG C, 5%CO2Under the conditions of cultivate 2 hours, after be transferred under liquid train
Support, incubation time is 3 days, and liquid is changed daily；
The nutrient solution II, is with DMEM：F12 contents are 3:Culture medium based on 1 culture medium, adding hyclone concentration is
20%, vitamin A acid concentration is 8 μ g/mL, and hEGF's concentration is 0.5ng/mL, and insulin concentration is 20.0 ng/mL, hydrogen
It is 0.5 μ g/mL to change cortisone concentration, and adenine concentration is 25.0 μ g/mL, and triiodothyronine concentration is 0.1 μ g/mL, thoroughly
Bright matter acid concentration is 0.1%, and flavones concentration is 8.0 μ g/mL, and glutamine concentration is 0.2g/L, and cholera toxin concentration is 1.0 μ
G/L, amphomoronal concentration is 1.0mg/L, and penicillin concn is 100.0 IU/mL, and streptomysin concentration is 100.0 μ g/mL；
Step 3: the gas-liquid face Proliferation, Differentiation culture of 3D models
Above-mentioned small indoor nutrient solution is discarded, the nutrient solution changed in model culture dish is nutrient solution III, makes liquid level and cell
Inner cell upper surface is located at same horizontal line, carries out gas-liquid face culture, and incubation time is 7 days, liquid is changed daily, culture terminates, 3D
The external structure of model terminates；
The nutrient solution III, is that in nutrient solution II, increase hydrocortisone concentration is 8.0 μ g/mL, and hyaluronic acid concentration is
0.5%, flavones concentration is 80.0 μ g/mL, and adds Vitamin E levels for 40.0 μ g/mL.
See figure using the keratin CK3 immunohistochemical staining results for the 3D models for immortalizing corneal epithelial cell external structure
2, illustrate similar to people's cornea using the 3D model proteins expression for immortalizing corneal epithelial cell external structure.
Embodiment 3：
The present embodiment highlights the external structure side of the 3D models using oral mucosa squamous cancer cell strain TR146 external structures
Method step：
Step 1: the preparation of cell
Oral mucosa squamous cancer cell strain TR146 is taken, after recovery amplification, using P14 for cell, is made with pancreatin digestion unicellular
Suspension, adjusts cell density 5.0 × 106Individual/mL, is inoculated in blake bottle, plus the nutrient solution I of 10% hyclone is cultivated, gently
Blake bottle is rocked, makes after cell is uniformly dispersed, to be placed in 37 DEG C, 5%CO2Under the conditions of cultivate；
The nutrient solution I, is DMEM, and its contained glucose content is 1.0g/L, and glutamine content is 0.2g/L.
Step 2: inoculated and cultured under the liquid of 3D models
Take the logarithm growth period cell, single cell suspension is made with nutrient solution II, adjustment cell density is 5.0 × 106Individual/mL, with
The volume of 200 μ L/ rooms, is inoculated in small interior, cell is placed in model culture dish, and appropriate nutrient solution II is added per ware, is made small
Indoor and outdoor liquid level is consistent, carries out immersion culture；It is placed in 37 DEG C, 5%CO2Under the conditions of cultivate 2 hours, after be transferred under liquid train
Support, incubation time is 2 days, and liquid is changed daily；
The nutrient solution II, is with DMEM：F12 contents are 3:Culture medium based on 1 culture medium, adding hyclone concentration is
10%, vitamin A acid concentration is 8 μ g/mL, and hEGF's concentration is 0.5 ng/mL, and insulin concentration is 30.0 ng/mL,
Hydrocortisone concentration is 1.0 μ g/mL, and adenine concentration is 50.0 μ g/mL, and triiodothyronine concentration is 0.1 μ g/mL,
Hyaluronic acid concentration is 0.3%, and flavones concentration is 8.0 μ g/mL, and glutamine concentration is 0.2g/L, and cholera toxin concentration is 1.0
μ g/L, amphomoronal concentration is 1.0mg/L, and penicillin concn is 100.0 IU/mL, and streptomysin concentration is 100.0 μ g/mL；
Step 3: the gas-liquid face Proliferation, Differentiation culture of 3D models
Above-mentioned small indoor nutrient solution is discarded, the nutrient solution changed in model culture dish is nutrient solution III, makes liquid level and cell
Inner cell upper surface is located at same horizontal line, carries out gas-liquid face culture, and incubation time is 6 days, liquid is changed daily, culture terminates, 3D
The external structure of model terminates；
The nutrient solution III, is that in nutrient solution II, increase hydrocortisone concentration is 8.0 μ g/mL, and hyaluronic acid concentration is
0.6%, flavones concentration is 100.0 μ g/mL, and adds Vitamin E levels for 50.0 μ g/mL.
Embodiment 4：
The present embodiment highlights the step of carrying out ET50 detections using the 3D models of primary corneal epithelial cell external structure：
1）Model is put into 6 orifice plates, 0.9 mL nutrient solution is added in orifice plate.
2）The Triton X-100 of 80 μ L 0.3% are drawn, are slowly added dropwise in tissue surface, it is ensured that reagent can be covered as far as possible
In tissue surface.
3）Administration time is respectively 0,30,60min.
4）After the administration of last block tissue, 6 all orifice plates are transferred in constant incubator（37±1℃、5±1%
CO2, 95% relative humidity）.
5）The 30min before tissue incubation terminates, 1 mg/mL MTT solution of preparation, and 300 μ L are added per hole to 24 orifice plates
MTT solution.
6）Administration starts washing procedure after terminating, using the wash bottle cleansing tissue equipped with sterile DPBS, after cleaning 10 times,
Tissue cultures cell innner and outer is embathed using DPBS each once.
7）By tissue that is cleaned and drying, it is transferred to and is tested added with MTT in 24 orifice plates of solution, in constant incubator
（37±1℃、5±1% CO2, 95% relative humidity）, it is incubated 3 hmin.
8）It is soft from orifice plate to suck MTT solution after the completion of MTT is incubated, to added in orifice plate DPBS solution carry out it is clear
Wash journey.
9）After washing is finished, tissue bottom surface is dried with blotting paper, is transferred in 24 new orifice plates, added in culture cell
Enter 2 mL isopropanols, it can dissolve the crystallization of MTT generations.24 orifice plate gaps are sealed using sealed membrane and avoid isopropanol volatilization shadow
Ring final volume.4 DEG C stand overnight dissolving.
10）After the completion of dissolving, for each tissue, 2 part of 200 μ L purple first a ceremonial jade-ladle, used in libation solution is drawn into same 96 orifice plate.
The parallel tissue of reprocessing, and according to the design transfer liquid of orifice plate, blank control is used as using isopropanol.Spectrophotometer
570 nm wavelength read absorbance, do not use optical filtering.
11）Culture terminates rear tissue activity and the curve map of 0.3% Triton X-100 action times under the liquid of 3D models
See Fig. 3, ET50 values can be calculated for 11.7min.The gas-liquid face culture of 3D models terminates rear tissue activity and 0.3% Triton
The curve map of X-100 action times is shown in Fig. 4, can calculate ET50 values for 59.6min.
Embodiment 5：
The present embodiment is highlighted carries out compound eye irritation using the 3D models for immortalizing corneal epithelial cell external structure
The step of detection：
1）Prepare sample
Experiment packet is carried out, sample group is 2 kinds of liquid chemical standard product, respectively dipropyl disulfide and N, N- diethyl
Meta-aminotoluene, wherein dipropyl disulfide belong to toluene between non-ocular harsh chemicals, N, N- diethyl in human trial
Amine human test results are ocular harsh chemicals, and negative control group is ultra-pure water, and positive controls are methyl acetate.
2）Security of test
（1）Every kind of 1 six orifice plate of tester preparation, prepare 46 orifice plates altogether.The DMEM that 0.9ml is added in each hole of first row is thin
Born of the same parents' nutrient solution, it is 0.5cm that a surface area is placed per hole2Vitro recombination corneal epithelium model.
（2）Tester and tester before processing, with the tissue table in 20 μ L Du Shi phosphate buffers process steps (1)
Face, in 36~37 DEG C, 5%CO under dark surrounds2, 95% relative humidity（Standard culture conditions）Incubator in, culture 15
Min, simulates human eye dampness.
（3）Tester is administered.All dosing techniques are carried out in superclean bench：A model is administered every 30s（When
Between can be indefinite, according to self administration time control, but must ensure that the administration time of each model is certain）, it is ensured that after administration,
Leave and sufficiently embathe time interval.In 0.5cm2Tissue surface is administered respectively, and dosage is 83.3 μ L/cm2（Fluidization
Product）Or 83.3mg/cm2（Solid chemical）, after administration, jog cell compartments promote tester sprawling in tissue surface,
At room temperature, 30min is incubated,.Note：Not pressable tissue surface.
（4）Administration time to the tissue of first administration terminates, and takes out vitro recombination corneal epithelium model, prepares three
Sterile 24 orifice plate, for cell viability detection.
（5）Start washing procedure.The each culture cell washing 30s of control, vitro recombination is washed with Du Shi hydrochlorate cushioning liquid
Corneal epithelium model 15 times, is wiped with sterile gauze or sterile swab stick.
（6）After cleaning terminates, in 36~37 DEG C, 5%CO2, under 95% relative humidity condition of culture, use fresh DMEM trainings
Support base cultured tissue 120min.
（7）MTT test by the vitro recombination corneal epithelium Model transfer of dry tack free to contain 1mg/mL tetrazolium bromide solution
24 orifice plates in, per hole 0.3mL, in 36~37 DEG C, 5% CO2, 95% humidity cell culture incubator in lucifuge be incubated 3 hours.
（8）Tetrazolium bromide solution is absorbed with pipettor, vitro recombination corneal epithelium model is totally submerged different containing 2mL to every hole
24 orifice plates of propyl alcohol, are sealed with sealed membrane, are stood and are extracted 12~16 hours at 4 DEG C, obtain the extract of isopropanol.
（9）Culture cell bottom is worn using 200 μ l pipettor gun spines, makes the isopropanol of vitro recombination corneal epithelium model
Extract is flowed in culture hole.200 μ l are drawn to isopropyl alcoholic extract into 96 orifice plates.
（10）Measure absorbance：Detected with 96 orifice plate spectrophotometers in the absorbance OD values that wavelength is 550~570nm.
（11）Judge excitant：Using the absorbance of negative control deionized water as denominator, respectively with test specimens dipropyl
The absorbance of disulfide and N, N- diethyl-m-toluidine is molecule, and the percentage of ratio is lived as respective versus cell
Power.As a result Fig. 5 is seen, the relative of dipropyl disulfide is 69.1%, and versus cell vigor is higher than 60%, so belonging to non-ocular stimulates
Property chemicals.The versus cell vigor of N, N- diethyl-m-toluidine is 20.7%, and versus cell vigor is less than 60%, illustrates N, N-
Diethyl-m-toluidine has excitant to ocular.（Versus cell vigor is higher than 60%, and detected chemicals is stimulated without ocular
Property, versus cell vigor is less than 60%, and detected chemicals has excitant.）
The general principle and principal character and advantages of the present invention of the present invention, the technical staff of the industry has been shown and described above
It should be appreciated that the present invention is not limited to the above embodiments, simply illustrate the present invention described in above-described embodiment and specification
Principle, without departing from the spirit and scope of the present invention, various changes and modifications of the present invention are possible, these change and
Improvement all fall within the protetion scope of the claimed invention, and the claimed scope of the invention is by appended claims and its equivalent
Thing is defined.
Claims (7)
1. a kind of 3D models built in vitro using system containing serum free culture system, it is characterised in that the model is application cell
Biology and engineering principles, the primary corneal epithelial cell separated using tissue, or limbal stem cell, or immortalize cornea
Epithelial cell, or primary Buccal mucosa cell, or mucous membrane of mouth squamous cancer cell strain TR146, after amplification in vitro, are used
Under serum-containing medium, and liquid-gas-liquid face subsection filter method, make its cladding, form external 3D models.
2. the 3D models according to claim 1 built in vitro using system containing serum free culture system, it is characterised in that described
Containing 5% ~ 20% hyclone FBS in serum-containing medium.
3. a kind of vitro construction method of utilization serum-containing medium external structure 3D models, it is characterised in that described utilize contains
The vitro construction method of serum free culture system liquid external structure 3D models includes following methods step：
Step 1: the preparation of cell
Primary corneal epithelial cell, or limbal stem cell are taken, or immortalizes corneal epithelial cell, or primary Oral mucosa keratinocyte
Cell, or mucous membrane of mouth squamous cancer cell strain TR146, after recovery amplification, using P4 ~ P20 for cell, list is made with pancreatin digestion
Cell suspension, adjusts cell density 5.0 × 104Individual/mL~5.0 × 106Individual/mL, is inoculated in blake bottle, plus containing 5% ~ 20% tire
The nutrient solution I of cow's serum is cultivated, and gently rocks blake bottle, makes after cell is uniformly dispersed, to be placed in 37 DEG C, 5%CO2Under the conditions of cultivate；
The nutrient solution I, is DMEM, its contained glucose content be 1.0~4.5g/L, glutamine content be 0.2g/L~
20.0g/L；
Step 2: inoculated and cultured under the liquid of 3D models
Take the logarithm growth period cell, single cell suspension is made with nutrient solution II, adjustment cell density is 5.0 × 104Individual/mL~5.0
×106Individual/mL, with the volume of 200 μ L/ rooms, is inoculated in small interior, cell is placed in model culture dish, and per ware, addition is appropriate
Nutrient solution II, makes small indoor and outdoor liquid level consistent, carries out immersion culture；It is placed in 37 DEG C, 5%CO2Under the conditions of cultivate 0.5~2
Hour, after be transferred under liquid cultivate, incubation time be 1~3 day, liquid is changed daily；
The nutrient solution II, is with DMEM：F12 contents are 3:1~1:Culture medium based on 3 culture medium, adds hyclone
Concentration is 5%~20%, and vitamin A acid concentration is 4~10 μ g/mL, and hEGF's concentration is 0.1~10.0 ng/mL, pancreas islet
Plain concentration is 5.0~50.0 ng/mL, and hydrocortisone concentration is 0.1~5.0 μ g/mL, and adenine concentration is 5.0~50.0
μ g/mL, triiodothyronine concentration is 0.1~10.0 μ g/mL, and hyaluronic acid concentration is 0.01%~0.1%, flavones concentration
For 5.0~50.0 μ g/mL, glutamine concentration is 0.2g/L~20.0g/L, and cholera toxin concentration is 1.0~100.0 μ g/
L, amphomoronal concentration is 1.0~10.0 mg/L, and penicillin concn is 10.0~100.0 IU/mL, and streptomysin concentration is
10.0~100.0 μ g/mL；
Step 3: the gas-liquid face Proliferation, Differentiation culture of 3D models
Above-mentioned small indoor nutrient solution is discarded, the nutrient solution changed in model culture dish is nutrient solution III, makes liquid level and cell
Inner cell upper surface is located at same horizontal line, carries out gas-liquid face culture, and incubation time is 1~7 day, liquid is changed daily, culture terminates,
The external structure of model terminates；
The nutrient solution III, is that in nutrient solution II, increase hydrocortisone concentration is 5.0~10.0 μ g/mL, hyaluronic acid
Concentration is 0.1%~1%, and flavones concentration is 50.0~150.0 μ g/mL, and adds Vitamin E levels for 20.0~80.0 μ g/
mL。
4. the vitro construction method of utilization serum-containing medium external structure 3D models according to claim 3, its feature
It is, the model construction time is 3 ~ 10 days.
5. the vitro construction method of the utilization serum-containing medium external structure 3D models according to claim 3 or 4, it is special
Levy and be, use ET50 methods（0.3% Triton X-100 make the time in model needed for half cell death）Detect the profit
With the barrier function of serum-containing medium external structure 3D models, after culture terminates under liquid, its ET50 is 5 ~ 15min.
6. the vitro construction method of the utilization serum-containing medium external structure 3D models according to claim 3 or 4, it is special
Levy and be, the barrier function of the utilization serum-containing medium external structure 3D models is detected using ET50 methods, in the training of gas-liquid face
Support after terminating, its ET50 is 30 ~ 70min.
7. the vitro construction method of the utilization serum-containing medium external structure 3D models according to claim 3 or 4, it is special
Levy and be, the model is applied to the eye thorn of the products such as micromolecular compound, activated protein, medicine equipment, chemicals, cosmetics
Swash property vitro detection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710460520.4A CN107164309B (en) | 2017-06-18 | 2017-06-18 | 3D model constructed outside serum-containing culture liquid and construction method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710460520.4A CN107164309B (en) | 2017-06-18 | 2017-06-18 | 3D model constructed outside serum-containing culture liquid and construction method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107164309A true CN107164309A (en) | 2017-09-15 |
| CN107164309B CN107164309B (en) | 2023-06-16 |
Family
ID=59819785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710460520.4A Active CN107164309B (en) | 2017-06-18 | 2017-06-18 | 3D model constructed outside serum-containing culture liquid and construction method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107164309B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110066847A (en) * | 2018-01-22 | 2019-07-30 | 广东博溪生物科技有限公司 | A kind of recombination cornea model and preparation method thereof for the evaluation of ocular irritation |
| CN112941014A (en) * | 2021-02-22 | 2021-06-11 | 深圳艾尼尔角膜工程有限公司 | Method for improving adhesion of tissue engineering anterior lamellar corneal epithelial cells |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020039788A1 (en) * | 2000-02-29 | 2002-04-04 | Isseroff Roslyn R. | Corneal epithelial graft composites |
| US20080026030A1 (en) * | 2004-06-30 | 2008-01-31 | Arblast Co., Ltd. | Corneal Epithelial Sheet and Process for Producing the Same |
| WO2010099643A1 (en) * | 2009-03-04 | 2010-09-10 | 中山大学中山眼科中心 | Method for promoting somatic cells proliferation |
| CN102166375A (en) * | 2011-02-16 | 2011-08-31 | 中国海洋大学 | Reconstruction method of tissue engineering human corneal epithelium |
| CN102952779A (en) * | 2012-11-30 | 2013-03-06 | 山东大学 | Cultural method for inducing human embryonic stem cell to directionally differentiate into corneal limbal stem cell |
| US20130251692A1 (en) * | 2010-12-02 | 2013-09-26 | Institut National De La Sante Et De La Recherche Medicale | Methods of generating corneal cells and cell populations comprising same |
| CN105255833A (en) * | 2015-10-13 | 2016-01-20 | 陕西博溪生物科技有限公司 | Oral mucosa epithelium model and in-vitro construction method thereof |
| CN106635962A (en) * | 2017-01-20 | 2017-05-10 | 李晖 | Construction method and application of human normal vaginal epithelium 3D (Three Dimensional) differentiation culture model |
-
2017
- 2017-06-18 CN CN201710460520.4A patent/CN107164309B/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020039788A1 (en) * | 2000-02-29 | 2002-04-04 | Isseroff Roslyn R. | Corneal epithelial graft composites |
| US20080026030A1 (en) * | 2004-06-30 | 2008-01-31 | Arblast Co., Ltd. | Corneal Epithelial Sheet and Process for Producing the Same |
| WO2010099643A1 (en) * | 2009-03-04 | 2010-09-10 | 中山大学中山眼科中心 | Method for promoting somatic cells proliferation |
| US20130251692A1 (en) * | 2010-12-02 | 2013-09-26 | Institut National De La Sante Et De La Recherche Medicale | Methods of generating corneal cells and cell populations comprising same |
| CN102166375A (en) * | 2011-02-16 | 2011-08-31 | 中国海洋大学 | Reconstruction method of tissue engineering human corneal epithelium |
| CN102952779A (en) * | 2012-11-30 | 2013-03-06 | 山东大学 | Cultural method for inducing human embryonic stem cell to directionally differentiate into corneal limbal stem cell |
| CN105255833A (en) * | 2015-10-13 | 2016-01-20 | 陕西博溪生物科技有限公司 | Oral mucosa epithelium model and in-vitro construction method thereof |
| CN106635962A (en) * | 2017-01-20 | 2017-05-10 | 李晖 | Construction method and application of human normal vaginal epithelium 3D (Three Dimensional) differentiation culture model |
Non-Patent Citations (1)
| Title |
|---|
| 王亚冬等: "气液界面培养体外构建角膜上皮的实验研究", 《中国临床康复》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110066847A (en) * | 2018-01-22 | 2019-07-30 | 广东博溪生物科技有限公司 | A kind of recombination cornea model and preparation method thereof for the evaluation of ocular irritation |
| CN112941014A (en) * | 2021-02-22 | 2021-06-11 | 深圳艾尼尔角膜工程有限公司 | Method for improving adhesion of tissue engineering anterior lamellar corneal epithelial cells |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107164309B (en) | 2023-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107326003A (en) | The 3D models and its construction method of a kind of utilization serum-free medium external structure | |
| Maharjan et al. | Symbiotic photosynthetic oxygenation within 3D-bioprinted vascularized tissues | |
| CN107849530A (en) | Blood vessel tissue, skin or mucous membrane equivalent | |
| CN102051343A (en) | Bioengineered tissue constructs and methods for producing and using them | |
| CN103458935A (en) | Methods of recellularizing a tissue or organ for improved transplantability | |
| CN103146650A (en) | Method for constructing three-dimensional neural stem cell model in two steps by adopting micro-fluidic technology | |
| CN103898058B (en) | A kind of three-dimensional culture method of novel gum knurl stem cell and its application | |
| Serban et al. | Effects of extracellular matrix analogues on primary human fibroblast behavior | |
| Rettinger et al. | Quantitative assessment of retina explant viability in a porcine ex vivo neuroretina model | |
| CN108504625A (en) | A kind of l cell and application thereof | |
| US11920153B2 (en) | Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures | |
| CN107164309A (en) | The 3D models and its construction method of a kind of utilization serum-containing medium external structure | |
| Takezawa et al. | A protein-permeable scaffold of a collagen vitrigel membrane useful for reconstructing crosstalk models between two different cell types | |
| US10928383B2 (en) | Method for predicting effect of drug | |
| Yu et al. | Emerging strategies of engineering retinal organoids and organoid-on-a-chip in modeling intraocular drug delivery: Current progress and future perspectives | |
| CN106834216A (en) | A kind of in vitro culture liquid and cultural method for the lonely female activation embryo of pig | |
| CN109486766A (en) | The cultivating system and cultural method of a kind of lachrymal gland stem cell, lachrymal gland stem cell | |
| CN106701668A (en) | Mesenchymal stem cell, as well as pure plant expansion method, separation method and application thereof | |
| CN116875530A (en) | NAME model simulating human brain immunity microenvironment and construction method thereof | |
| CN1795266B (en) | Method for producing retinal neurocyte from neural stem cell derived from iris tissue and retinal, neurocyte produced by the process | |
| CN103074300A (en) | Co-culture system establishment of mesenchymal stem cells and tumor cells as well as mesenchymal stem cells heredity stability change characteristic in tumor microenvironment | |
| CN114869911B (en) | Application of PD-1 cell membrane nano vesicle combined stem cell membrane in postoperative treatment of malignant melanoma | |
| CN104755610B (en) | Fat tissue cell | |
| CN107372302B (en) | The animal model for having an impact large biological molecule to cellular biology of tumor is screened in vivo | |
| CN106244522A (en) | A kind of stem cell cultivating system and cultural method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |